Changsha Huiheng Laimi Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Changsha Huiheng Laimi Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YUME. The owner is based in Changsha.

Room 447, Building 2, Xincheng Science and Technology Park

588 Yuelu West Avenue,High tech Development Zone

Changsha 410000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YUME
YUME
Registered 2025

Trademark Classifications

Changsha Huiheng Laimi Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Changsha Huiheng Laimi Technology Co., Ltd have?

Changsha Huiheng Laimi Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changsha Huiheng Laimi Technology Co., Ltd file in?

Changsha Huiheng Laimi Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Changsha Huiheng Laimi Technology Co., Ltd's most well-known trademarks?

Changsha Huiheng Laimi Technology Co., Ltd's registered trademark portfolio includes well-known marks such as YUME. These are among 1 currently registered trademark in the portfolio.

What is Changsha Huiheng Laimi Technology Co., Ltd's trademark registration success rate?

Changsha Huiheng Laimi Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.